The sale is small and follows a same-day option exercise, typical of an officer covering taxes or realizing compensation. No material signal, monitor for any larger insider sales or cluster activity in the coming weeks.
Price Chart
Executive Summary
Lauren Riker, an officer of Pacira BioSciences, filed a Form 144 on October 8, 2026, indicating intent to sell 6,000 shares of common stock with an approximate market value of $217,920. The shares were acquired via stock option exercise on the same day. This is a relatively small sale relative to the company's market cap and appears to be a routine exercise-and-sell transaction.
Key Facts
- Insider: Lauren Riker (Officer)
- Shares to be sold: 6,000 shares of common stock
- Estimated value: $217,920
- Acquisition: Stock option exercise on 10/08/2026
- Filing date: 2026-10-08
- Broker: Fidelity Brokerage Services LLC
Financial Impact
Sale of 6,000 shares valued at approximately $217,920, less than 0.1% of market cap based on typical biotech valuations
Risk Factors
- Insider selling ahead of potential negative catalyst (though no evidence here)
- Additional unregistered sales by other insiders could emerge
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-007312 |
| Document: 0001959173-26-007312-index.html | 0001959173-26-007312 |
| Document: 0001959173-26-007312.txt | 0001959173-26-007312 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 15d ago | SC 13D/A | $36.40 | awaiting T+20 | awaiting T+20 | $36.38 (+0.05%) |
Oct 8, 2026 20d ago | SC TO-C | $36.31 | awaiting T+20 | awaiting T+20 | $36.38 (+0.19%) |
Oct 8, 2026 21d ago | 144 | $36.39 | awaiting T+20 | awaiting T+20 | $36.38 (−0.03%) |
Oct 8, 2026 21d ago | 8-K | $36.39 | awaiting T+20 | awaiting T+20 | $36.38 (−0.03%) |
Oct 8, 2026 21d ago | SC TO-C | $36.39 | awaiting T+20 | awaiting T+20 | $36.38 (−0.03%) |
Aug 6, 2026 12w ago | Press Release | $25.58 $26.60 | ▲ +3.99% | ▲ +3.39% | $36.38 (+42.22%) |
Jul 22, 2026 14w ago | Press Release | $25.59 $24.36 | ▼ −4.81% | ▼ −7.70% | $36.38 (+42.16%) |
Jun 30, 2026 17w ago | 8-K | $25.37 $26.47 | ▲ +4.34% | ▲ +5.36% | $36.38 (+43.40%) |
Jun 12, 2026 19w ago | Insider Cluster | $22.74 $25.54 | ▲ +12.31% | ▲ +13.06% | $36.38 (+59.98%) |
Jun 4, 2026 20w ago | DEFA14A | $22.75 $25.59 | ▲ +12.48% | ▲ +10.62% | $36.38 (+59.91%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers